1.29. Analysis.
Comparison 1 Cholinesterase inhibitor (optimum dose) vs placebo, Outcome 29 Number who suffered at least one adverse event of ecchymosis before end of treatment at 6 months or later.
Comparison 1 Cholinesterase inhibitor (optimum dose) vs placebo, Outcome 29 Number who suffered at least one adverse event of ecchymosis before end of treatment at 6 months or later.